Decreasing insulin resistance and increasing adiponectin levels reduces atherosclerotic and inflammatory processes and endothelial dysfunction [35-37] and may thus have decreased the cardiovascular risk in both study groups. This evidence concerns the gene ADIPOQ and Insulin resistance.